|
KLHDC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.484100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.361300E-03 |
| Normal-vs-Stage2 |
4.013500E-02 |
| Normal-vs-Stage3 |
6.939000E-01 |
| Normal-vs-Stage4 |
4.123600E-01 |
| Stage1-vs-Stage2 |
7.688200E-01 |
| Stage1-vs-Stage3 |
3.947000E-01 |
| Stage1-vs-Stage4 |
7.471600E-01 |
| Stage2-vs-Stage3 |
3.308000E-01 |
| Stage2-vs-Stage4 |
5.713400E-01 |
| Stage3-vs-Stage4 |
7.754400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.200000E-03 |
| Normal-vs-AfricanAmerican |
2.366000E-01 |
| Normal-vs-Asian |
5.868800E-01 |
| Caucasian-vs-AfricanAmerican |
4.492800E-01 |
| Caucasian-vs-Asian |
4.239200E-01 |
| AfricanAmerican-vs-Asian |
4.871800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.441200E-04 |
| Normal-vs-Female |
5.459000E-01 |
| Male-vs-Female |
1.502470E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.696100E-03 |
| Normal-vs-Extreme_Weight |
3.8009000000061E-05 |
| Normal-vs-Obese |
2.606800E-01 |
| Normal-vs-Extreme_Obese |
2.919700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.830400E-01 |
| Normal_Weight-vs-Obese |
2.665600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.719000E-01 |
| Extreme_Weight-vs-Obese |
6.678400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.546200E-01 |
| Obese-vs-Extreme_Obese |
4.110800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.780200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.236800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.635600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.497600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.546600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.043240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.948100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.239600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.891750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.029000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.472000E-02 |
| Normal-VS-Type2 PRCC |
3.75120000000173E-05 |
| Normal-VS-KIRP CIMP |
2.090400E-01 |
| Normal-VS-Unclassified PRCC |
9.344200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.527890E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.824100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.746600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.617900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.310000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.022600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.042120E-02 |
| Normal-vs-N1 |
3.811600E-01 |
| Normal-vs-N2 |
9.462400E-01 |
| N0-vs-N1 |
1.815910E-02 |
| N0-vs-N2 |
3.857800E-01 |
| N1-vs-N2 |
7.841400E-01 |
|
|
